HWAM
GWPH

Hennion & Walsh Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Hennion & Walsh Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-56,212
Closed -$12.2M – 768
2021
Q1 		$12.2M Buy
+56,212
New +$10.6M 0.73% 20

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Hennion & Walsh Asset Management's GWPH Position: Q2 2021 in Review

Hennion & Walsh Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 56,212 shares — an estimated $12.2M sold.

Hennion & Walsh Asset Management first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $12.2M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Hennion & Walsh Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 56,212 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $12.2M.
  • Hennion & Walsh Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Hennion & Walsh Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $12.2M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.